Details of the Drug

General Information of Drug (ID: DM4H78P)

Drug Name
NT-501
Synonyms
NTC-201E; CNTF cell implant (ECT), Neurotech; CNTF ophthalmic cell implant (retinitis pigmentosa), Neurotech; Cell implant (ciliary neurotrophic factor), Neurotech; Cell implant (retinitis pigmentosa, ECT), Neurotech
Indication
Disease Entry ICD 11 Status REF
Ocular inflammation 9C61.24 Phase 2/3 [1]
Retinitis pigmentosa 9B70 Phase 2/3 [2]
Macular telangiectasia type 2 9B75.3 Phase 2 [2]
Cross-matching ID
TTD ID
D0A7WO
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Ciliary neurotrophic factor receptor alpha (CNTFR) TTT2F9E CNTFR_HUMAN Modulator [3]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT00447980) A Study of Encapsulated Cell Technology (ECT) Implant for Participants With Early Stage Retinitis Pigmentosa. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of Neurotech.